億緯鋰能(300014.SZ):第六期員工持股計劃鎖定期將屆滿
格隆匯 11 月 6日丨億緯鋰能(300014.SZ)公佈,2019年11月13日,公司在巨潮資訊網披露《關於第六期員工持股計劃完成股票購買的公告。截至該公告日,億緯鋰能6號已通過二級市場以競價交易方式累計買入公司股票50.42萬股,成交金額合計1978.18萬元,成交均價為39.23元/股。億緯鋰能6號所購買的股票鎖定期為2019年11月13日至2020年11月12日。
公司第六期員工持股計劃鎖定期屆滿,該員工持股計劃鎖定期屆滿後,億緯鋰能6號將根據市場情況通過二級市場交易等法律法規許可的方式賣出其持有的全部公司股票。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.